These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
500 related articles for article (PubMed ID: 27811355)
1. Clinical and immunohistochemical characteristics of type II and type I focal cortical dysplasia. Yao K; Duan Z; Zhou J; Li L; Zhai F; Dong Y; Wang X; Ma Z; Bian Y; Qi X; Li L Oncotarget; 2016 Nov; 7(47):76415-76422. PubMed ID: 27811355 [TBL] [Abstract][Full Text] [Related]
2. Intraoperative ultrasonography (ioUS) characteristics of focal cortical dysplasia (FCD) type II b. Prada F; Gennari AG; Del Bene M; Bono BC; Quaia E; D'Incerti L; Villani F; Didato G; Tringali G; DiMeco F Seizure; 2019 Jul; 69():80-86. PubMed ID: 30999253 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics, pathological features and surgical outcomes of focal cortical dysplasia (FCD) type II: correlation with pathological subtypes. Yao K; Mei X; Liu X; Duan Z; Liu C; Bian Y; Ma Z; Qi X Neurol Sci; 2014 Oct; 35(10):1519-26. PubMed ID: 24744193 [TBL] [Abstract][Full Text] [Related]
4. Focal cortical dysplasias in temporal lobe epilepsy surgery: Challenge in defining unusual variants according to the last ILAE classification. Martinoni M; Marucci G; Rubboli G; Volpi L; Riguzzi P; Marliani F; Toni F; Naldi I; Bisulli F; Tinuper P; Michelucci R; Baruzzi A; Giulioni M Epilepsy Behav; 2015 Apr; 45():212-6. PubMed ID: 25812941 [TBL] [Abstract][Full Text] [Related]
5. Neuroimaging in identifying focal cortical dysplasia and prognostic factors in pediatric and adolescent epilepsy surgery. Kim YH; Kang HC; Kim DS; Kim SH; Shim KW; Kim HD; Lee JS Epilepsia; 2011 Apr; 52(4):722-7. PubMed ID: 21275980 [TBL] [Abstract][Full Text] [Related]
6. Clinical, imaging, and immunohistochemical characteristics of focal cortical dysplasia Type II extratemporal epilepsies in children: analyses of an institutional case series. Knerlich-Lukoschus F; Connolly MB; Hendson G; Steinbok P; Dunham C J Neurosurg Pediatr; 2017 Feb; 19(2):182-195. PubMed ID: 27885945 [TBL] [Abstract][Full Text] [Related]
7. Cytochrome c oxidase deficit is associated with the seizure onset zone in young patients with focal cortical dysplasia Type II. Miles L; Greiner HM; Mangano FT; Horn PS; Leach JL; Miles MV Metab Brain Dis; 2015 Oct; 30(5):1151-60. PubMed ID: 25957585 [TBL] [Abstract][Full Text] [Related]
8. Epilepsy surgery of focal cortical dysplasia-associated tumors. Cossu M; Fuschillo D; Bramerio M; Galli C; Gozzo F; Pelliccia V; Casaceli G; Tassi L; Lo Russo G Epilepsia; 2013 Dec; 54 Suppl 9():115-22. PubMed ID: 24328884 [TBL] [Abstract][Full Text] [Related]
9. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons. Rossini L; Villani F; Granata T; Tassi L; Tringali G; Cardinale F; Aronica E; Spreafico R; Garbelli R Epilepsy Res; 2017 Jan; 129():146-156. PubMed ID: 28056425 [TBL] [Abstract][Full Text] [Related]